KESHA TRAN: Open Payments
NPI 1467857987 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 50 payments from 18 companies in 2025. Trend: 2023 $1,018 · 2024 $1,321 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $376 |
| Braeburn Inc. | 3 | $175 |
| Gilead Sciences, Inc. | 5 | $98 |
| Lilly USA, LLC | 4 | $69 |
| Astellas Pharma US Inc | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Novo Nordisk Inc | 2 | $34 |
| Dexcom, Inc. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: VRAYLAR, BRIXADI, MAVYRET, QULIPTA, MOUNJARO, Veozah, UBRELVY, LEQVIO.
Industry payments across FL — which companies pay providers there.
